• Text size      
  • Send this article to a friend
  • Print this article

Vaccination could cut down cases of cancer

Vaccinating against the virus that causes glandular fever could prevent up to 200,000 cases of cancer worldwide each year, according to Cancer Research UK.

More work is needed to develop a vaccine against Epstein-Barr Virus (EBV), which is linked to a number of cancers, it said.

Research funded by the charity led to the identification of the virus and its association with cancer 50 years ago.

Cancer Research UK scientist Professor Alan Rickinson, from the University of Birmingham, said: "We now know so much about how the virus contributes to the development of particular types of cancer.

"The next big challenge is to develop a vaccine that will prevent infection by the virus."

Around 95% of the global adult population is infected with EBV. Many people pick up the virus in childhood and carry it for life with no ill effects.

Others infected as teenagers may develop glandular fever but make a full recovery - but in some individuals the virus can trigger cancer.

Contextual targeting label: 

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.